Klotho vs MOTS-c
Side-by-side comparison of Klotho, MOTS-c — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Klotho Klotho (α-Klotho) — Anti-Aging Protein/Peptide Longevity | MOTS-c Mitochondrial Open Reading Frame of the 12S rRNA-c Longevity |
|---|---|---|
| Basics | ||
| Molecular type | Anti-Aging Protein (Klotho Fragment) | Mitochondria-Derived Peptide |
| Amino acids | — | 16 |
| Molecular weight | — | 2,174.5 Da |
| Half-life | Hours (circulating KL1 fragment) | Short (hours) |
| Route(s) | Subcutaneous (research), IV (research) | Subcutaneous, IV (research) |
| Mechanism & Research | ||
| Primary mechanism | Klotho acts as a co-receptor for fibroblast growth factor 23 (FGF23) in the kidney, regulating phosphate and vitamin D metabolism. However, its systemic anti-aging effects extend far beyond this co-receptor role through … | MOTS-c activates AMPK (AMP-activated protein kinase), the master energy sensor of the cell. AMPK activation inhibits anabolic energy-consuming pathways, stimulates glucose uptake, drives fatty acid oxidation, and promote… |
| Research status | Research Compound | Research Compound |
| Evidence summary | Klotho research has expanded dramatically since 2000. The most compelling recent finding was a 2023 Nature paper showing a single injection of Klotho fragment in aged mice produced sustained cognitive improvements — one … | MOTS-c research has expanded rapidly since its discovery in 2015. Human plasma MOTS-c levels correlate inversely with age and with metabolic disease risk, supporting its physiological relevance in human ageing. |
| Protocol & Dosing | ||
| Typical dose | Not established for human use; animal models used 10–100 mcg/kg | 5–10 mg per week |
| Frequency | Unknown optimal frequency | 2–3x per week |
| Duration | Experimental | 4–8 weeks |
| Timing | Not established | Pre-exercise or morning |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Not Prohibited |
| Deeper reading | ||
| Related peptides | Epithalon, Humanin, MOTS-c | Humanin, SS-31, Epithalon |
| Full profile | Read full Klotho profile → | Read full MOTS-c profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.